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Abstract
Detection of microorganisms by blood cultures (BCs) is essential in managing patients with bacteraemia. Rather than the number of punctures,
the volume of blood drawn is considered paramount in efﬁcient and reliable detection of microorganisms.We performed a 1-year prospective
multicentre study in adult emergency departments of three French university hospitals comparing twomethods for BCs: a unique blood culture
(UBC)collecting a large volumeof blood (40 mL) and the standardmethodofmultiple bloodcultures (MBC).Theperformancesofbothmethods
for bacterial contamination and efﬁcientmicrobial detectionwere compared, each patient serving as his owncontrol. Amongst the2314patients
included, three hundred were positive for pathogens (n = 245) or contaminants (n = 55). Out of the 245 patients, 11 were positive for
pathogens byUBCbut negative byMBC and seven negative byUBCbut positive byMBC (p 0.480). In the subgroup of 137 patients with only two
BCs, UBC was superior to MBC (p 0.044). Seven and 17 patients had contaminated BCs by UBC and MBC only, respectively (p 0.062).
Considering the sumsof pathogensmissed and contaminants,UBC signiﬁcantly outperformedMBC(p0.045).Considering the complete picture
of cost savings, efﬁcient detection of microorganisms and decrease in contaminations, UBC offers an interesting alternative to MBC.
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Introduction
Detection of bacteraemia and fungaemia by blood culture (BC)
is essential in managing patients with bloodstream infection
(BSI) [1]. Many studies have shown that increasing the number
of BCs increases the likelihood of isolation of microorganisms
[2–5]. It is a standard recommendation that two to four BCs
should be obtained over a 24-h period for the optimal
detection of BSIs in adults [6,7].
The volume of blood drawn is now considered para-
mount in efﬁcient detection of microorganisms. This notion
is based on many studies of patients with bacteraemia [4,8–
12]. Li et al. demonstrated that increasing cultured volume
from 20 to 40 mL increased yield by 19% [9]. Collecting
only one BC should be discouraged because it results in an
inadequate volume of cultured blood and therefore lacks
sufﬁcient sensitivity for detecting BSI [6]. Also, it is more
challenging to distinguish between contamination and true
bacteraemia.
Contaminated BCs may lead to longer hospital stays,
unnecessary antibiotic therapy, redundant laboratory testing,
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unnecessary removal of the catheter in patients with a central
venous line and induce wasteful spending [13]. The multiple
venipunctures required to obtain several sets of BCs are all
opportunities for contamination.
To reconcile the need to collect large volumes of blood for
efﬁcient diagnosis of BSI and the need to minimize the
contaminations by limiting the number of venipunctures, we
have designed a prospective multicentre study comparing a
unique BC (UBC) collecting a large volume of blood (40 mL)
with the standard method of multiple BC (MBC) in patients
presenting to the emergency department with a suspicion of
BSI. We hypothesized that a UBC would decrease the number
of contaminations and detect a similar number of pathogens, as
compared with MBC.
Materials and Methods
Study design
This prospective, comparative, multicentre study involved
emergency departments of three French university hospitals in
Caen (1495 beds), Lille (2965 beds) and Rouen (2445 beds). The
study included BCs obtained from consecutive patients aged
≥18 years from January to December 2012. However, the study
had to be interrupted for holidays because of staff shortages.
BCs were collected from patients admitted with one of the
following signs: fever (≥38.5°C), hypothermia (≤36°C), chills or
shock.
For the ﬁrst BC, 40 mL of blood was obtained aseptically by
a single phlebotomy and equally distributed into two BacT/
Alert FA aerobic bottles and two BacT/Alert FN anaerobic
bottles (bioMerieux, La-Balme-les-Grottes, France). The four
bottles were labelled prior to the venipuncture from one to
four, in the following order, aerobic-anaerobic-aerobic-
anaerobic, and ﬁlled in according to the numbering. Within
the next 24 h, one to three other 20-mL BCs consisting of a
single pair of aerobic and anaerobic bottles had to be
performed, spaced by a minimum of 30 min. Bottles were
incubated for 5 days or until positivity was reported by the
BacT/Alert 3D instrument (bioMerieux).
The study was designed to compare the UBC and the MBC
methods, with each patient being his own control: for MBC
analysis, the ﬁrst bottle pair was mimicked by taking into
account the culture results of the ﬁrst two bottles of the UBC
set (see Supplementary Fig. S1). Hereafter, the mimicked MBC
was called MBC.
The exclusion criteria were the following: patients
<18 years, patients for whom direct venipuncture was impos-
sible, patients who had an invasive procedure during the ﬁrst
24 h of hospitalization, patients for whom the ﬁrst four-bottle
set was not labelled or labelled in incorrect order, and patients
for whom subsequent two-bottle sets were not obtained.
Clinicians were free to prescribe two or more BCs. Skin
disinfection was performed using similar protocols in the three
centres based on alcoholic povidone-iodine as a disinfectant
before each venipucture.
This study was submitted to and approved by the local
ethics committee. Given the observational nature of this study,
in accordance with French legislation, written information was
delivered to the patients or, if not possible, to their relatives.
Deﬁnitions of contaminants and pathogens
Microorganisms isolated from BCs were studied by standard
microbiological techniques. A positive BC was deﬁned as
growing with one or several microorganisms, regardless of the
number of bottles.
Contaminants. Cultures of coagulase-negative staphylococci
(CoNS) (aside from Staphylococcus lugdunensis), coryneform
bacteria, non-pneumococcal viridans streptococci, Propionibac-
terium, Bacillus and Micrococcus species, whatever the number
of positive BCs, were considered as potential contaminations.
The number of positive bottles and clinical data (including
fever, chills, hypotension, neutropenia, antibiotic administra-
tion, catheter management and bacteriology of infected sites)
were reviewed to evaluate the clinical signiﬁcance of a
potentially contaminated BC. Infectious diseases physicians
conducted medical reviews (see Supplementary Appendix S1
for more details). In particular, the presence of CoNS in more
than one set of BCs was considered as a contamination when
the species identiﬁcations or antibiotic susceptibility proﬁles
were different and when the physician review indicated no
clinical evidence of infection.
Pathogens. Other organisms, such as E. coli or Staphylococcus
aureus, not requiring several positive sets of BCs to be
considered as pathogens, were classiﬁed as pathogens in the
study [2]. When bacteraemia were polymicrobial, each
microorganism was investigated independently.
Statistical analysis
Assuming that 2% of BCs (i.e. 20% of positive BCs) would be
contaminated, including a level of contaminants of 8% or more
in MBC only and 2.7% in UBC only (three times less because
UBC gives rise to three less opportunities for contamination
compared with MBC), we planned to include 200 positive BCs
to be able to demonstrate a signiﬁcant reduction of contam-
inants in UBCs as compared with MBCs. The culture results of
UBCs were compared with those of MBCs. Analyses were
carried out separately and then combined for pathogens and
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contaminants. The number of patients with discordant results
for contaminants and pathogens was compared by using the
McNemar’s chi-square test. The a-level was set at 0.05 for
statistical signiﬁcance.
Results
Patients
From January to December 2012, a ﬁrst set of four bottles was
obtained from 2314 unique patients (1551 in Caen, 461 in Lille
and 302 in Rouen) (Fig. 1). At the end, a total of 300 patients
had a ﬁrst four-bottle set and subsequent two-bottle set
drawn and were positive for pathogens or contaminants (13%)
(Caen, n = 202, 13%; Lille, n = 76, 16.5%; Rouen, n = 22,
7.3%). Two BCs were performed for 170 positive patients and
≥3 BCs were requested for 130 positive patients. The mean
patient age was 67.3  18 years (range, 18–92 years); 56.8%
were male.
Contaminant microorganisms
Conﬁrmed contaminants were detected in 55 patients (2.4%
overall, 1.6% in Caen, 6.8% in Lille and 1.7% in Rouen).
Pathogens also grew in BCs of four of these patients (three E.
coli and one S. aureus). Data for these four patients were
analysed independently for contaminants and pathogens.
Thirty-one patients had contaminated BCs by both UBC and
MBC strategies. As expected, most contaminants (n = 25)
were detected in the ﬁrst aerobic bottle that accounted for
both the UBC and MBC groups. Seven patients had a
contaminated UBC only and 17 had a contaminated MBC only
(p 0.062). Contamination of the second set of BCs (n = 16)
accounted for the lower performance of MBCs. Bacterial
species isolated as contaminants are shown in Table 1.
FIG. 1. Enrollment and follow-up of
studied patients.
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Pathogens
Pathogens grew in the BCs collected from 249 patients
(10.8%). After review of medical records of discrepancies
between the UBC and MBC groups, four patients with
microorganisms detected by MBC but not by UBC were
excluded from the study due to clinical invasive investigations
performed after the collection of the ﬁrst set of BCs. Indeed,
two patients underwent urinary catheterization and endo-
scopic retrograde cholangiography, respectively, just before
the second set of BCs positive for E. coli. The other two
patients underwent abscess draining and ascites puncture just
prior to the fourth BC positive for S. aureus and b-haemolytic
streptococci, respectively.
Among the 245 remaining positive patients, 11 were
positive for pathogens by UBC but negative by MBC, while
seven were negative by UBC but positive by MBC (p 0.480)
(Fig. 2). Discrepant microbial and clinical diagnoses are shown
in Table 2. A sub-analysis was carried out according to the
number of BCs performed in patients. In the group of 137
patients for whom only two BCs were performed, the
difference between patients positive only with UBC and those
positive only with MBC was statistically signiﬁcant (10 vs. 2; p
0.044) (Fig. 2). Differences were not statistically signiﬁcant for
the 61 and 47 patients who underwent three and four sets of
BCs, respectively (p 0.618 and p 0.480), as well as after
combining patients with ≥3 BCs (p 0.221) (Fig. 2).
Overall, UBC allowed detection of pathogens in the blood
of 97.4% of patients vs. 95.5% for MBC (89.8% with the ﬁrst
mimicked set of MBCs and 94.7% with the ﬁrst two BCs)
(Fig. 2). The difference between UBC and MBC was due to the
lower performance of MBC in the two-BC subgroup (Fig. 3).
The percentage of positive BCs was greater (99%) in the
sub-group of 108 patients with ≥3 BCs. The rank order of
pathogens isolated from BCs is shown in Table 3. E. coli
accounted for nearly one-third of isolates, which is consistent
with the community origin of BSIs.
Twenty-one patients (8.4%) had polymicrobial bacteraemia,
including 17 and four with two and three microorganisms,
respectively. As compared with UBC, MBC allowed isolation
of additional pathogens in six of these BCs (Table 4).
Conversely, UBC detected two additional pathogens as
compared with MBC.
Global assessment of UBC and MBC
As the goal of this study was to compare UBC with MBC both
for efﬁcient isolation of blood pathogens and for minimization
of BC contaminants, we have designed an additional statistical
analysis accounting for both parameters. Considering the sums
of patients with pathogens missed and contaminated BCs, the
difference between performances of UBC and MBC was
statistically signiﬁcant (p 0.045) (Fig. 4).
Discussion
Adequate volume sampling appears to be the most important
parameter for detecting bloodstream microorganisms because
bacterial density in blood from bacteraemic patients is very
low (median 1 CFU/mL). Sampling an adequate blood volume
can be achieved either by increasing the number of venipunc-
tures or by collecting more blood at each venipuncture. The
TABLE 1. Contaminant microorganisms from blood cul-
tures
Bacterial species Number of isolates
UBC and MBC positive
Coagulase-negative staphylococci 27
Streptococcus viridans 1
Coryneform bacteria 2
Micrococcus sp. 2
Bacillus sp. 1
UBC positive and MBC negative
Coagulase-negative staphylococci 6
Streptococcus viridans 1
UBC negative and MBC positive
Coagulase-negative staphylococci 14
Streptococcus viridans 3
Total
Coagulase-negative staphylococci 47
Streptococcus viridans 5
Coryneform bacteria 2
Micrococcus sp. 2
Bacillus sp. 1
Total 57a
aIn two patients, one in the UBC group and the other in the MBC group, two
contaminants were detected.
FIG. 2. Discrepancies in detection of pathogens between the unique
blood culture (UBC) and the multiple blood culture (MBC). Numbers
of patients with bacteraemic episodes by UBC only or by MBC only
are shown. Data are shown for all patients and for patients with two,
three or four sets of blood cultures (SBC) by MBC.
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ﬁrst strategy has been successful in several studies [5,9,14].
However, despite recommendations, a study by the American
College of Pathologists showed that the incidence of solitary
BCs leading to collect a maximum of 20 mL of blood, ranged
from 1 to 99% (median 26%) at 38 surveyed institutions [15].
In a more recent study by the same College, single BCs were
performed in 42.5% or more in the less performing 10% of 333
small US hospitals [16]. In a recent study from a large French
hospital, only 45% of patients had ≥2 BCs [17]. The second
strategy was used by Patel et al., who reported that collection
of two sets of three bottles resulted in a 7.9% increased yield
as compared with two bottles per set [12]. A single
phlebotomy strategy collecting a large volume of blood
provides several advantages. It does not delay antimicrobial
therapy and increases the chance of isolating the causal
microorganism in the case of severe sepsis where antimicrobial
therapy has to be started after the ﬁrst set of BCs.
Furthermore, the risk of contamination mathematically
increases with the number of venipunctures. In a recent study,
when comparing the number of contaminated BCs with
collection of two 30-mL BC sets with the number following
the collection of one 20-mL BC set, the increased contaminant
yield was 23.0% for the two 30-mL BC sets [12]. The
theoretical possibility of intermittent bacteraemia that sup-
ports the concept of the MBC strategy has never been proved
[9,18]. A presumed intermittent bacteraemia may turn to a
continuous bacteraemia if the volume of sampled blood is
increased.
Few studies have evaluated performances of a single
collection of a large volume of blood. On the basis of a
theoretical model and literature-based simulations, Lamy et al.
proposed collection of a unique six-bottle BC set [19]. This
Patient (hospital) Bacterial species Infection
Signiﬁcant underlying
disease
UBC positive and MBC negative
1 (Caen) Enterobacter cloacae EVD infection Glioblastoma
2 (Caen) Streptococcus agalactiae Erysipelas
3 (Caen) Streptococcus mitis Pneumonia
4 (Caen) Bacteroides sp. Bacterial translocation Colorectal cancer
5 (Caen) Escherichia coli Pneumonia Cirrhosis
6 (Caen) Escherichia coli Pyelonephritis
7 (Lille) Streptococcus agalactiae Erysipelas
8 (Lille) Escherichia coli Pyelonephritis
9 (Rouen) Streptococcus pneumoniae Pneumonia Diabetes mellitus
10 (Rouen) Staphylococcus aureus Bacteraemia from skin lesion IVUD
11 (Rouen) Staphylococcus aureus Bacteraemia Panhypopituitarim
UBC negative and MBC positive
12 (Caen) Escherichia coli Pyelonephritis IT
13 (Caen) Escherichia coli Pyelonephritis Diabetes mellitus
14 (Caen) Escherichia coli Sigmoid diverticulitis
15 (Caen) Escherichia coli Pyelonephritis
16 (Caen) Fusobacterium sp. Foot osteomyelitis Cirrhosis, PVT, HCC
17 (Lille) Streptococcus pneumoniae Pneumonia
18 (Lille) Staphylococcus aureus Pneumonia
EVD, external ventricular drain; IVUD, intravenous drug use; IT, immunosuppressive therapy; PVT, portal vein
thrombosis; HCC, hepatocellular carcinoma.
TABLE 2. Microbiological and clini-
cal diagnosis of discrepancies betwe-
en UBC and MBC strategies
FIG. 3. Percentages of patients with bacteraemic episodes by the
unique blood culture (UBC) and the multiple blood cultures (MBC)
methods. Data are shown for all patients (n = 245) and for patients
with ≥3 sets of blood cultures (n = 108) and according to the number
of blood cultures performed. SBC, set of blood cultures.
TABLE 3. Rank order of pathogen microorganisms isolated
from blood
Bacterial species or group Number of isolates (%)
Escherichia coli 94 (35)
Staphylococcus aureus 41 (15.2)
Other Enterobacteriacae 24 (8.9)
b-haemolytic streptococci 21 (7.8)
Streptococcus pneumoniae 21 (7.8)
Anaerobes 20 (7.4)
Enterococcus spp. 13 (4.8)
Streptococcus viridans 10 (3.6)
Coagulase-negative staphylococci 8 (3)
Pseudomonas spp. 6 (2.2)
Streptococcus gallolyticus 6 (2.2)
Aeromonas sp. 1 (0.4)
Candida albicans 1 (0.4)
Cryptococcus neoformans 1 (0.4)
Listeria monocytogenes 1 (0.4)
Pasteurella multocida 1 (0.4)
Total 269 (100)
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strategy was shown to be superior to a multisampling
strategy. However, getting enough blood for six bottles from
a single puncture may be difﬁcult, particularly in elderly
patients. To the best of our knowledge, only one published
study has used a single-sample strategy based on inoculating a
40-mL BC [20]. The increased yield of true bacteraemia using
a 40-mL instead of 30-mL BC was estimated to be 4.2%. The
authors, who used a before/after design, concluded that
resources were optimally used and that this strategy had a
positive impact on workload management and early antimi-
crobial therapy.
We used a study design in which the patient was his own
control, allowing accurate comparisons between the UBC and
MBC strategies. Surprisingly, 48% of the 2314 patients had a
solitary BC. This percentage is similar to that reported
previously [12–17]. We did not investigate the reasons for this,
but it may be that unnecessary BCs are common in emergency
departments [21,22].
Although statistical signiﬁcance was not reached, the UBC
strategy allowed detection of four more positive patients than
the MBC strategy. Analysis of subgroups of patients revealed
that statistical signiﬁcance was reached when UBC was
compared with the MBC subgroup with two BCs. In the
subgroup of 108 patients with ≥3 BCs, four more pathogens
were detected by the MBC strategy, although the difference
with UBC was not signiﬁcant. This could be related to the
minimum of 60 mL of blood that was drawn, as opposed to
40 mL with the UBC strategy. However, this was paid by an
increase in contaminants (ﬁve more) related to the multisam-
pling strategy. By combining the efﬁciency in detection of
microorganisms and the minimization of contaminants, the
UBC strategy showed signiﬁcant superiority over the standard
MBC strategy (Fig. 4).
There is compelling evidence that contaminated BCs have a
signiﬁcant negative ﬁnancial impact and deleterious effects on
patient’s management [13,23–26]. False-positive BCs have
been shown to increase patient charges by 47%, with an
over-cost reaching $8720 per contamination [24]. Souvenir
et al. reported that almost half of the patients with a
false-positive result were treated with antibiotics, often with
vancomycin, leading to additional costs of $1000 per patient
[25]. BC contaminations have been shown to generate a 20%
and 39% increase in laboratory and intravenous antibiotic
charges, respectively [26].
Comparing UBC with the standard MBC with two, three
and four sets of BCs, the cost savings related to less material
and labour time should amount to 58 500 €, 159 000 € and
259 500 € for 10 000 BCs, respectively (see Supplementary
Appendix S2).
An important point to consider is that our study was
deliberately conducted without modifying routine prescrip-
tions of clinicians. Therefore, global trends of the UBC
strategy towards isolation of less contaminants and more
pathogens as compared with the routine MBC reﬂects the
daily practice in our three hospitals. Finally, a single 40-mL BC
is likely to be more accepted by patients than several
venipunctures and involves half the work or two-thirds less
work for phlebotomists.
FIG. 4. Comparison of the technique of unique blood cultures (UBC)
with that of multiple blood cultures (MBC) for patients with
contaminations (white bars) and missed pathogens (black bars).
TABLE 4. Discrepancies between UBC and MBC strategies for patients with polymicrobial bacteraemia
Microorganisms
Type of infection Underlying conditionIsolated by UBC and MBC Isolated only by MBC Isolated only by UBC
Escherichia coli Klebsiella pneumoniae - Acute cholangitis
Enterococcus faecalis Prevotella spp. - Cholecystitis
Proteus mirabilis Pseudomonas aeruginosa - Urinary tract infection Peritoneal carcinosis;
obstruction of JJ stent
Escherichia coli, Enterococcus faecalis Pseudomonas aeruginosa - Sigmoid diverticulitis Cirrhosis, ascites
Morganella morganii, Eubacterium spp. Parabacteroides sp. - Colorectal cancer with
digestive occlusion
Bacteroides sp. Anaerobic Gram-positive,
Bacillus spp.
- Peritonitis Colorectal cancer
Staphylococcus aureus - Bacteroides fragilis Epidural catheter with
abdominal reservoir
Citrobacter freundii, Streptococcus milleri - Klebsiella pneumoniae Acute cholangitis
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There are limitations to our study. The patients enrolled in
the study presented to the emergency department mostly
with community-acquired infections. We have not evaluated
the UBC strategy for patients with hospital-acquired infec-
tions. Further studies are needed, in particular for candidemia,
which have low organism density in blood [27]. Another point
is that drawing of multiple sets helps to distinguish a
contaminated BC related to skin contaminants from ‘true’
bacteraemia. In our study most of the contaminants were
isolated in one or two bottles of the four of the UBC set, in
accordance with a previous report [20]. Therefore, the clinical
signiﬁcance of putative contaminants should be evaluated
according to the number of positive bottles in the UBC
strategy instead of the number of BCs in the MBC strategy
[28]. Further studies are needed to evaluate more precisely
the number of positive bottles required for clinical signiﬁ-
cance.
The results of UBC for polymicrobial bacteraemia deserve
some attention. Indeed, MBC allowed isolation of additional
pathogens in six BCs vs. two with UBC. Although isolation of
additional anaerobic bacteria had no signiﬁcant therapeutic
impact in our study, the MBC strategy might keep some
interest in intra-abdominal infections.
In conclusion, it is crucial to consider the complete picture
regarding both collecting BCs using best practice by taking the
optimum volume of blood and decreasing costs induced by
contaminations and multisampling. The UBC strategy offers an
interesting alternative to MBC that should be considered for
most patients, except for immunocompromised patients with
suspicion of candidaemia.
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